跳至主要内容
临床试验/ISRCTN15441965
ISRCTN15441965已完成未知

The clinical and cost effectiveness of temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: a pragmatic, randomised, normal care-controlled clinical trial

niversity of Nottingham (UK)0 个研究点目标入组 1,774 人开始时间: 2013年4月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,774

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Male or female aged 16 years and over
  • 2. Clinician diagnosed asthma treated with a licensed dose of inhaled corticosteroid (i.e. step 2 to 4 of the British Thoracic Society [BTS] /Scottish Intercollegiate Guidelines Network [SIGN] guidelines)
  • 3. One or more exacerbation in the last 12 months requiring treatment with systemic corticosteroids

排除标准

  • Potential participants will be excluded on the basis of:
  • 1. History more in keeping with smoking related chronic obstructive pulmonary disease [COPD] (smoked > 20 pack years, without evidence of significant reversibility and eosinophilia)
  • 2. On maintenance oral steroids (i.e. step 5 BTS/SIGN guidelines)
  • 3. Using a combination inhaler for both maintenance and relief treatment
  • 4. Experienced an exacerbation within 4 weeks of randomisation
  • 5. Pregnant women, lactating women or women who are planning to become pregnant

研究者

发起方
niversity of Nottingham (UK)

相似试验

FAST - four-fold asthma study: the clinical and cost... | 临床试验